Literature DB >> 15149289

Attention disorders in schizophrenia.

Hiroshi Suwa1, Eisuke Matsushima, Katsuya Ohta, Katsumi Mori.   

Abstract

In order to clarify the feature of attention disorders in schizophrenia, two tasks (X and AX) of the Continuous Performance Test (CPT) were given to 36 schizophrenic patients and 25 healthy controls. The schizophrenic patients performed considerably less well than normal controls. Performances were expressed in indices such as omission and commission errors, reaction time and discriminability. Among errors, omission in both the X and AX tasks was found to be an index that varied in reaction time, indicating difficulty in sustaining attention. Omission was found to act as a state-dependent index of schizophrenia in relation to inattentiveness in clinical settings and emotional disturbance in interpersonal situations. Commission, in contrast, differed between the two tasks, acting as an index of disinhibition of reaction in the X task, and of disturbance of the capacity and allocation of attention in the AX task. Commission was also thought to be an index related to thought disorder during episodes of acute schizophrenia, that is, it reflects an essential pathology in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149289     DOI: 10.1111/j.1440-1819.2004.01227.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  8 in total

1.  Structural analysis of the basal ganglia in schizophrenia.

Authors:  Daniel Mamah; Lei Wang; Deanna Barch; Gabriel A de Erausquin; Mokhtar Gado; John G Csernansky
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

2.  Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine.

Authors:  David M Thomson; Allan McVie; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2010-09-29       Impact factor: 4.530

Review 3.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

4.  The neurobehavioural evaluation in schizophrenics: a comparative study.

Authors:  Kamini Ramdas Ilamkar
Journal:  J Clin Diagn Res       Date:  2013-01-01

Review 5.  Sustained attention in psychosis: Neuroimaging findings.

Authors:  Gianna Sepede; Maria Chiara Spano; Marco Lorusso; Domenico De Berardis; Rosa Maria Salerno; Massimo Di Giannantonio; Francesco Gambi
Journal:  World J Radiol       Date:  2014-06-28

6.  Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.

Authors:  R L Openshaw; D M Thomson; J M Penninger; J A Pratt; B J Morris
Journal:  Psychopharmacology (Berl)       Date:  2016-10-24       Impact factor: 4.530

7.  Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome.

Authors:  Adam C Cunningham; Sue Delport; Wendy Cumines; Monica Busse; David E J Linden; Jeremy Hall; Michael J Owen; Marianne B M van den Bree
Journal:  Br J Psychiatry       Date:  2018-01       Impact factor: 10.671

8.  Relationships between cognitive performance, clinical insight and regional brain volumes in schizophrenia.

Authors:  Erkan Alkan; Simon L H Evans
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.